ClearPoint Neuro (CLPT) Change in Accured Expenses (2011 - 2026)
ClearPoint Neuro (CLPT) posted Change in Accured Expenses of -$437000.0 for Q1 2026, up 93.03% sequentially from -$6.3 million in Q4 2025, and up 84.84% YoY from -$236424.6 in Q1 2025.
ClearPoint Neuro (CLPT) Change in Accured Expenses (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported Change in Accured Expenses for 15 years, with the latest figure at -$437000.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 84.84% year-over-year to -$437000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.1 million (down 539.77% YoY) and the FY2025 annual result came in at -$7.5 million, down 342.19% from the prior year.
- Change in Accured Expenses grew to -$437000.0 in Q1 2026 per CLPT's latest filing, from -$6.3 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $1.7 million in Q4 2024 and troughed at -$6.3 million in Q4 2025.
- A 5-year average of -$230000.0 and a median of $374000.0 in 2023 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 443.4% in 2022, down 1181.48% in 2022.
- Over 5 years, Change in Accured Expenses stood at $336000.0 in 2022, then grew by 11.31% to $374000.0 in 2023, then surged by 363.1% to $1.7 million in 2024, then tumbled by 461.95% to -$6.3 million in 2025, then jumped by 93.03% to -$437000.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$437000.0, -$6.3 million, and $693000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 4.80 Mn |
| 10 | ClearPoint Neuro | 466.38 Mn | 436.98 Mn | 6.71 Mn | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.21 Mn |
| Jun 30, 2026 | 1.21 Mn |
| Mar 31, 2026 | -437,000.00 |
| Mar 31, 2026 | -437,000.00 |
| Dec 31, 2025 | -6.27 Mn |
| Dec 31, 2025 | -6.27 Mn |
| Sep 30, 2025 | 693,000.00 |
| Sep 30, 2025 | 693,000.00 |
| Jun 30, 2025 | 938,000.00 |
| Jun 30, 2025 | 938,000.00 |
| Mar 31, 2025 | -2.88 Mn |
| Mar 31, 2025 | -2.88 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Sep 30, 2024 | 647,000.00 |
| Sep 30, 2024 | 647,000.00 |
| Jun 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | -931,000.00 |
| Mar 31, 2024 | -931,000.00 |